GEMIPAR 500 are suppositories that contain paracetamol. Paracetamol has analgesic and antipyretic effects. The medicine is intended for adults and adolescents over 12 years of age.
Short-term treatment of mild and moderate pain, e.g. headaches, toothaches, joint, muscle and bone pain, pain after surgical and dental procedures. Fever, e.g. in the course of a cold or flu in patients who cannot take paracetamol orally, e.g. due to nausea or vomiting.
Do not use the medicine if:there is hypersensitivity to any component of the medicine, severe renal impairment, severe liver impairment, congenital lack of glucose-6-phosphate dehydrogenase and methemoglobin reductase, alcoholism, first trimester of pregnancy.
The medicine contains paracetamol. To avoid overdose, check if other medicines being taken do not contain paracetamol.
Do not use doses higher than recommended. Use with caution in elderly patients. Use with caution in patients with liver or kidney impairment. During paracetamol treatment, do not consume alcohol due to the risk of severe liver damage.
Particular risk of liver damage exists in malnourished individuals and those who regularly consume alcohol.
Do not use in children under 12 years of age.
The medicine is contraindicated in the first three months of pregnancy. Paracetamol may be used in the second and third trimester of pregnancy and during breastfeeding in case of urgent need and after consulting a doctor.
Before using any medicine, consult a doctor.
The medicine does not affect psychophysical abilities.
Paracetamol enhances the effect of oral anticoagulant medicines from the coumarin group, prolonging bleeding time and increasing the risk of bleeding. Using paracetamol with zidovudine (AZT) may enhance the toxic effect of zidovudine on the bone marrow. Concurrent use of paracetamol and medicines that increase liver metabolism, e.g. rifampicin, antiepileptic medicines, barbiturates, increases the risk of liver damage, even when using recommended doses of paracetamol. Paracetamol prolongs the half-life of chloramphenicol and increases its toxicity. Concurrent administration of paracetamol and non-steroidal anti-inflammatory medicines increases the risk of kidney function disorders. Using paracetamol with MAO inhibitors may cause excitement and high fever (a 14-day interval should be maintained). Metoclopramide accelerates, and propanteline delays the absorption of paracetamol from the gastrointestinal tract. Consuming alcohol during paracetamol treatment may lead to liver failure due to liver cell necrosis. Using paracetamol may cause false results in some laboratory tests (e.g. glucose concentration measurement). Do not use with other medicines containing paracetamol.
Inform the doctor about all medicines taken recently, even those available without a prescription.
Adults and adolescents over 12 years of age, rectally 1 suppository at a time. If necessary, the dose can be repeated every 4 hours, but no more than 4 times a day.
The medicine should not be used for more than 3 days without consulting a doctor.
If you feel that the effect of the medicine is too strong or too weak, consult a doctor.
The following may occur: nausea, vomiting, excessive sweating, drowsiness, and general weakness. These symptoms may resolve the next day, despite the fact that liver damage is beginning to develop, which will then manifest as abdominal distension, return of nausea, and jaundice.
In case of taking a larger dose of the medicine than recommended, consult a doctor or pharmacist immediately.
Due to the pharmaceutical form (suppositories), overdose of the medicine is unlikely, however, it cannot be ruled out in the event of concurrent oral administration of paracetamol.
Treatment of paracetamol overdose given orally involves inducing vomiting if it has been less than an hour since administration, and administering activated charcoal.
In case of taking very large doses of the medicine, antidotes are administered: methionine and acetylcysteine treatment is continued.
The medicine is used for symptomatic treatment. If a dose is missed and the symptoms persist, take the next dose of the medicine. Do not use a double dose to make up for the missed dose.
Like any medicine, GEMIPAR 500 can cause side effects, although they may not occur in everyone.
Rarely
Store the medicine in a place inaccessible and invisible to children.
Do not use the medicine GEMIPAR 500 after the expiry date stated on the packaging.
Store at a temperature below 25°C. Store in the original packaging.
To obtain more detailed information, contact the responsible entity:
Biofaktor Sp z o.o.
ul. Podmiejska 15 C
66-400 Gorzów Wielkopolski
e-mail: sekretariat@biofaktor.pl
Date of preparation of the leaflet:
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.